Diagnostics

Point-of-Care Diagnostics Platform

OPKO Diagnostics, formerly Claros Diagnostics, Inc., has developed a point-of-care system able to produce laboratory-quality results in about ten minutes. The device includes a pipeline of diagnostic tests and a portable hardware device, and it has been acclaimed for its innovation in multiple publications.

Laboratory Quality Immunoassays

Immunoassays comprise the largest family of in-vitro diagnostics, and they are primarily used to detect proteins. They include tests for infectious diseases, cancer, and immune diseases, among others.

Interior Cassette with Blood Sample


Due to their complexity, immunoassays typically can be only performed in large laboratories with expensive equipment and trained technicians. This limits their use to hospital or outsourced contract laboratory settings and often leads to days of waiting for lab test results.

OPKO’s groundbreaking diagnostic system is equipped to perform these complex immunoassay blood tests directly at the point-of-care in only about ten minutes.

Point-of-Care Convenience

OPKO is developing a point-of-care system based on this platform, including a pipeline of diagnostic tests and a portable hardware device.

OPKO’s diagnostic system has the potential to implement:

  • Multiple tests simultaneously (multiplexing)
  • Many types of complex in-vitro diagnostic assays, such as immunoassays, nucleic acid tests, hematology, coagulation, and cell counting
  • Creation of diagnostic / therapeutic combinations designed to improve patient access to adequate therapies
  • Monitoring of the use of therapeutics in patient treatment programs

Potential Applications:

  • Neurological conditions
  • Female healthcare
  • Metabolic disorders
  • Thyroid disorders
  • Ovulation
  • Heart disease
  • Infectious diseases
  • Cancer

OPKO Diagnostics Card Technology Applications

Urologist Office

OB/GYN Office

Emergency Room

Clinic and Blood Bank

GP Office

PSA Panel: Panel Tests: Cardio Panel: STD Panel: Key Tests:
Total PSA Pre-term Bleed CTnl HIV TSH, T4
Free PSA Fertility BNP Hepatitis B Vitamin D
Testosterone Menopause D-dimer Syphilis Folic Acid
Novel Markers

 

Recognition for OPKO Diagnostics:

Claros product named a finalist in the Wall Street Journal’s 2011 Technology Awards:
http://online.wsj.com/article/SB10001424052970203633104576623261551755704.html

Claros technology successfully tested in Africa:
http://www.nature.com/nm/journal/v17/n8/full/nm.2408.html